It has been reported that CD155, widely expressed in human and mouse tumor-infiltrating myeloid cells, promotes tumor cell growth and metastasis by down-regulating the expression of CD226 and inhibiting the effects of CD8+T and NK cells (33). This evidence concerns the gene CD8A and neoplasm.